A millennial fighting a rare form of cancer has hit back at Joe Biden's claim that his presidency would "cure cancer," and credited President Trump's administration with saving her life.
An on-the-ground investigation in Pennsylvania finds unprotected radioactive material next to a popular bike and walking ...
For those suffering from primary bone cancer — which is cancer that originates in the bones — a promising new medication may be on the horizon. The drug, called CADD522, works by blocking a gene ...
A 15-year-old Copperas Cove girl battling stage 4 bone cancer says a summer camp for pediatric cancer patients gave her ...
Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news. If you’re interested in reporting on any of this month’s stories, contact media@fredhutch.org ...
Bioactive glasses, a filling material which can bond to tissue and improve the strength of bones and teeth, has been combined with gallium to create a potential treatment for bone cancer. Tests in ...
Researchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer. Cancer that starts in the bones, rather than cancer that has ...
Bioactive glasses, a filling material which can bond to tissue and improve the strength of bones and teeth, has been combined with gallium to create a potential treatment for bone cancer. Tests in ...
Ewing sarcoma is a type of bone cancer. However, it can also begin outside of the bones in the body’s soft tissues. In some cases, Ewing sarcoma may begin in the soft tissues and muscles rather than ...
Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has puzzled medical researchers for 40 years. Now, a new study by researchers at Case ...
Osteoporosis is most common in older adults, but some types of cancer and cancer treatment can also contribute to its development. Osteoporosis is a loss of bone mineral density that makes you more ...
Many patients with metastatic castration-resistant prostate cancer are not receiving bone-modifying agents, despite guideline endorsement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results